Things were rocky at the start but the future looks bright now!
The analyst community considers Veradigm a strong buy. Why?
The stock hasn’t been able to gain value in the last 4 years or so, It’s cheap and it fluctuates. What’s the catch?
Do you agree that the stock could skyrocket?
MDRX never rose in value even though the company is showing promising financial results and good stability year after year. To put it another way, there is a big discrepancy between the company’s financial performance and growth and the value of its... — read more
Q4 2022
I remember when the stock price was $22. Now the price is much lower and I personally expect it to be even lower when the financial results are announced. Maybe someone here has a prediction of how the publication of the results will affect the... — read more
How come the good Q3 results didn’t set a rising trend for the stock?
I really felt this could be a breaking point which could put the stock on a good rising trend. Yet the stock still keeps running around in circles.
A cheap stock that can go a long way
I’m sure that many here agree with me. While Allscripts seems to be for some reason under the radar of the media that cover the stock market, many investors and analysts speak highly of it. The earnings to stock value ratio is excellent. Without... — read more
Well this Allscripts was a waste of money and time.
I purchased Allscripts a little less than a year ago and so far no good came from it. I guess the upside is that I didn’t lose money on it, but now it is clear from my perspective that this stock has no potential to produce any sort of value. I... — read more
A good long-term investment
I’ve bought Allscripts shares recently. Given that all of my investments are long–term I feel as this is a nice addition to my portfolio. People that I know tend to stay away from investments like this with the explanation that they cannot produce... — read more
Very tempting stock right now
Here's the thing, I really don't like investing in health care companies in general. Among many other reasons is the competition that I think is more pronounced than in any other sector. However, MDRX really got my attention lately. It has been... — read more